Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5610.00    120.00 (2.19%)
Bid:
5570.00
Ask:
5580.00
Spread: 10.00 (0.18%)
Market Cap: £3.00b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
17th Dec 20197:00 amRNSAcquisition of premium pig farming business
10th Dec 20192:56 pmRNSHolding(s) in Company
6th Dec 20192:14 pmRNSHolding(s) in Company
2nd Dec 20192:52 pmRNSTotal Voting Rights
26th Nov 20197:00 amRNSInterim Results
25th Nov 20194:54 pmRNSHolding(s) in Company
5th Nov 20194:49 pmRNSHolding(s) in Company
4th Nov 20194:08 pmRNSHolding(s) in Company
4th Nov 20193:50 pmRNSTotal Voting Rights
4th Nov 201911:09 amRNSTotal Voting Rights
1st Oct 20199:14 amRNSTotal Voting Rights
1st Oct 20199:07 amRNSBlock listing Interim Review
1st Oct 20199:00 amRNSBlock listing Interim Review
30th Sep 20191:52 pmRNSDirector/PDMR Shareholding
16th Sep 201911:49 amRNSDirector/PDMR Shareholding
16th Sep 201911:47 amRNSDirector/PDMR Shareholding
6th Sep 20199:54 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSIssue of Equity
2nd Sep 201910:42 amRNSTotal Voting Rights
2nd Sep 201910:42 amRNSHolding(s) in Company
22nd Aug 201912:56 pmRNSHolding(s) in Company
21st Aug 201911:15 amRNSHolding(s) in Company
13th Aug 20192:18 pmRNSHolding(s) in Company
6th Aug 20194:48 pmRNSHolding(s) in Company
30th Jul 20196:21 pmRNSTotal Voting Rights
30th Jul 20192:45 pmRNSHolding(s) in Company
29th Jul 20193:49 pmRNSPoll Result for 2019 Annual General Meeting
29th Jul 20197:00 amRNSFirst Quarter Trading Update and Acquisition
25th Jul 20191:54 pmRNSDividend Declaration
22nd Jul 20196:25 pmRNSHolding(s) in Company
3rd Jul 20196:33 pmRNSHolding(s) in Company
3rd Jul 20192:07 pmRNSDirector/PDMR Shareholding
3rd Jul 20192:06 pmRNSDirector/PDMR Shareholding
3rd Jul 20192:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20192:02 pmRNSDirector/PDMR Shareholding
3rd Jul 20192:01 pmRNSDirector/PDMR Shareholding
3rd Jul 20192:00 pmRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSHolding(s) in Company
1st Jul 20195:27 pmRNSHolding(s) in Company
1st Jul 201910:00 amRNSTotal Voting Rights
27th Jun 20194:07 pmRNSHolding(s) in Company
25th Jun 20191:51 pmRNSDirector/PDMR Shareholding
25th Jun 20191:49 pmRNSDirector/PDMR Shareholding
20th Jun 20197:00 amRNSDirector/PDMR Shareholding
20th Jun 20197:00 amRNSDirector/PDMR Shareholding
10th Jun 201911:00 amRNSDirector Declaration
6th Jun 20194:18 pmRNSDirector/PDMR Shareholding
5th Jun 20198:44 amRNSDirector/PDMR Shareholding
3rd Jun 201910:05 amRNSTotal Voting Rights
21st May 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.